Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK
Asia Pacific & Middle East
Canada

Cancer Summit 2022

About us

We are an organization that amalgamates and International science events for the benefit of the global scientific community. The organization was established in the year 2007 with the sole aim of providing a platform for "Open Access" to the research information pertaining to diversified fields of Science and technology. We published that can be easily accessed online without paying any subscription charges. Our organization plays an instrumental role in expanding the reach of research data in the real time, which in turn helps in furthering the research. Research Scholars, Students, Libraries, Educational Institutions, Research centres and industries are the main stakeholders that are benefitted from open access to research data. We also organize 3000+ across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.

Dr. Srinubabu

 

About Webinar

Dear Colleagues,

 

Conference Series welcome you to the webinar ”4th Asia Pacific Oncology and Cancer Conference” during February 10-11, 2022 London, UK with a theme “Explore the Latest Innovative Treatment and Prevention of Oncology and Cancer Challenges”.

 

Cancer Summit 2022, webinar will focus on educational research directed toward its impact on clinical outcomes through oral and poster presentations, educational workshop sessions and influential plenary presentations. Cancer Summit 2022 is a perfect platform to find out how Cancer and Oncology research innovations helpful to the Medical, Health and human society. Cancer Summit 2022 will mainly focus on the trending topics during presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of Cancer, Oncology and medical sectors. This includes prompt Keynote Presentations, Oral Talks, Poster Presentations, Video Presentations and Exhibitions.

 

Overview of Oncology and Cancer:

 

The Innovative idea of Cancer has started great many researches to be embraced by the labs around the world. An extraordinary number of researchers and scientists taking a shot at Caner research, till date, no significant solution for this is recorded. Global Cancer will also provide two days of discussions on techniques and systems identified with administration and quality change of Cancer and in addition to investigate the new thoughts and ideas on worldwide scale and the themes incorporate lung malignancy, bosom disease, bone tumour, leukaemia, blood cancer, cervical tumour, colon-rectum disease, paediatric malignancy, surgical tumour, Prostate growth, thyroid malignancy.

 

Global market is segmented into Europe, North America, Latin America, Asia Pacific, Middle East and Africa. According to market study, Market Value for Oncology will be more than double to $ 623 Million by 2020. A major part of the research is going on the top Universities across the globe. So many companies are associated with various Cancer Screening and Diagnostics instruments and other therapeutics. Besides this various societies, associations and research centres are also associated in this research field.

 

Target Audience:

 

Cancer Pharmaceutical Companies

Research scholars

Pathologist

Students

Diagnostics companies

Medical Practitioners

Industrial Researchers

Academicians

Directors, Head of Department

Chemotherapists

Research and Development Department.

Business Delegates

Medical Colleges

Rehabilitation Specialists

Genetic scientists

Cancer Associations

Diagnostic Laboratory Professionals

Hospital presidents/CEOs/COOs/VPs/trustees

Hospital c-suite executives (operations, development, finance)

Oncology specialists (medical, radiation, and surgical)

Oncology program and practice administrators, managers, and service line executives

Healthcare consultants, vendors, and suppliers

Cancer program marketing and public relations professionals

Exhibitors and people with keen interest in the research areas of Cancer Research.

Who should sponsor/exhibit:

 

Basic and Translational Laboratory Researchers      

Hospitals

Educational Institutes

Research Centres

Charitable Foundations focused on funding research, advocating for and supporting the needs

Why to attend?

 

Oncology and Cancer will enlighten the people with the most recent advancements in Cancer diagnosis, Cancer Science, Cancer therapy, Cancer treatment etc., around the world and to glow the related research ideas regarding Cancer Research & Oncology.

 

The aim of the webinar is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.

 

 Benefits of Attending the Webinar:

 

Networking Opportunities, Grow Your Professional Network

Build Your Knowledge Base

Expand Your Resources

Learning in a New Space

Break Out of Your Comfort Zone

New Tips & Tactics

Top Industries Representation

Abstracts will be published in the webinar souvenir and respective International journals

Each Abstract will receive unique (DOI) Number provided by Cross Ref

Website visibility to more than 35K visitors in less than 6 months

Laudable talks by the top-notch of the Global Scientific Community

The Serendipity of the Random Workshop

Will be felicitated with International Organizing Committee Member (IOCM)

Remarkable Awards and Global Recognition to meritorious Researchers

 

Sessions & Tracks

Track 1: Fields of Oncology

 

Oncology/Cancer is the branch of medicine that researches, identifies and treats cancer. A physician works in the field of oncology/Cancer is an oncologist.

 

Oncologists must first diagnose cancer, which is usually carried out via biopsy, endoscopy, X-ray, CT scanning, MRI, PET scanning, ultrasound or other radio logical methods. Nuclear medicine techniques can also be used to diagnose cancer as can blood tests or tumour markers. Oncology is often linked with haematology. Oncology, which is the branch of medicine that deals with blood and blood-related disorders.

 

Track 2: Types of Oncology

 

Oncology is the study of tumour or cancer. Most of the tumours are not cancerous. The cancerous tumours are called malignant tumours. Commonly oncology implies the study of malignant tumours or cancer. The doctor who practices oncology is an oncologist. There are different kinds of oncologists. Those who practiced in surgery are called surgical oncologists. Those who practiced in radiation therapy are called radiation oncologists. Those who practiced in the care of persons with cancer and administer chemotherapy are medical oncologists.

 

Track 3: Solid tumour

 

An abnormal mass of tissue and cells that generally does not contain cysts or liquid areas. Solid tumours may be benign Tumours (not cancer), or malignant (cancer). Different categories of solid tumours are named for the type of cells. Some of the examples of solid tumours are sarcomas, carcinomas, and lymphomas. Leukaemia’s (cancers of the blood) usually do not form solid tumours.

 

One common carcinoma is adrenocortical carcinoma. This is when a tumour progresses in one or both adrenal glands, located above each kidney.

 

Track 4: Neurosurgical Oncology

 

Neurosurgical Oncology is a complex surgical method that presupposes treatment, diagnosis, and rehabilitation of disorders affecting any region of the Nervous System. Some of the preponderance is common Neuro surgeries are skull base surgery, Image Guided Surgery, Laser Surgery, Spinal Neurosurgery and Neuro surgical treatment.

 

Track 5: Nursing Oncology

 

A Nursing Oncology will gives care to growth patients and those are in danger for getting the sickness. They screen physical conditions, recommend solution and oversee chemotherapy and many medications for cancer. Oncology and Cancer is a standout among the most crucial and remunerating fields in nursing. One of the crucial parts of the cancer nurture is quiet appraisal. They are in charge of surveying patients who have initiated because of treatment reactions, and also evaluating patients, amid and post-chemotherapy. The oncology nurture necessary to have the capacity to comprehend pathology comes about and their suggestions, and have an inside and out learning of the normal symptoms of growth medicines. The oncology nurture like to utilize her relational aptitudes to tune in to the patient, surveying their comprehension of the malady and its procedure and also the patient's passionate state.

 

Track 6: Medical & Radiation Oncology

 

Radiation Oncology enclosed all aspects of research that impacts the treatment of oncology using radiation. Radiotherapy can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may be used palliative, to relieve symptoms in patients with incurable cancers. Radiotherapy is expensively segmented into Radiotelegraphy, Brachy-radiotherapy and Metabolic Radiotherapy.

 

Track 7: Neuro Oncology

 

The Central Nervous System is denounced to various malevolent personality disorders. Central Nervous System covers its mechanism, Metastatic pestilence, Ramification, Cancers, Neurons and Sensory Receptors, Neurological Disorders, Multiple sclerosis and Imaging agents to CNS neurofibromatosis. Cancer spreads to the Nervous System by direct invasion or compression from continuous tissues relates to the proximity of the Nervous System to other structures. Central Nervous System Drugs market to grow at a CAGR of -3.2% over the period 2013-2018. The central nervous system (CNS) therapeutics peddle has been forecast to reach US$133 billion by the year 2018, which increases in disease ubiquity rates due to increase in population, introduction of new drugs, and increased outgo on healthcare.

 

Track 8: Brain Tumour

 

Brain Tumour develops when abnormal cells form inside the brain. The symptoms of Brain stem tumours vary greatly and can involve Ataxia, Cranial Nerve Palsy, headaches, problems with speech and swallowing, hearing loss, weakness, Hemiparesis, vision abnormalities, ptosis, and behavioural changes. Another possible symptom is vomiting. Any brain tumour  is inherently serious and life-threatening because of its infiltrative character in the limited space of the Intracranial Cavity.

 

Track 9: Cancer Cell Biology and genetics

 

Due to Cancers millions of death occurring every year. The study of cancer biology is one of the largest areas of scientific interest. Cancer cells progress specific hallmarks through a series of mutations in both oncogenes and tumour-suppressor genes. There is no definitive cure for cancer, the most of the cancer treatments serve to prolong the lives of cancer sufferers.

 

Track 10: Cancer Biomarkers

 

A Cancer biomarker refers to a substance that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted a particular response of the body to the presence of cancer. Genetic, epigenetic, proteomic and imaging biomarkers can be utilized for cancer diagnosis, prognosis, and epidemiology. Ideally, likewise biomarkers can be assayed in non-invasively collected bio fluids like blood or serum.

 

Track 11: Cancer metabolomics

 

Cancer metabolomics research is being used to discover diagnostic cancer biomarkers in the clinic, to better understand its complex heterogeneous nature, to discover pathways involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. Cancer metabolomics approaches may also provide clues to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate goal of most Cancer Metabolomics studies is to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient.

 

Track 12: Organ-Defined Cancers

 

Cancer can occur anywhere in the body. The most common sites of cancer among men involve lung, prostate, colon, rectum, stomach, Brain and liver. Those for among women are breast, colon, rectum, lung, cervix, ovarian and stomach. Cancers are often described by the body part that originated in. Some body parts contain multiple types of tissue, so for greater precision, cancers can additionally be classified by the type of cell that the tumour cells originated from. The type of cancer a person has needed to be known properly as many types of cancer can behave very differently and respond to different treatments.

 

Track 13: Cancer: Psychological Aspects

 

If one is fighting cancer, it is common to experience psychological distress. Whether it is coping with the diagnosis, the challenges of treatment or continued worry about a recurrence, emotions brought on by the cancer experience can be crucial to handle.

 

Track 14: Lifestyle Changes to Improve Your Cancer Care

 

How we live can have pro­found effects on our health and wellness. This also applies for people who have cancer. A healthy lifestyle can support cancer treatments and help you to cure better. It may also improve your long-term health.

 

Track 15: Cancer Epigenetics and Oncogenomics

 

Cancer is a genetic disease affected by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The ambition of oncogenomics is to determined new oncogenes or tumour suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies like Gleevec, Herceptin and a vast in raised the hope for oncogenomics to elucidate new targets for cancer treatment.

 

Track 16: Cancer Screening and Diagnostics

 

Cancer screening tests goal to find cancer early, before it causes symptoms and when it may be easier to treat successfully. Effective screening tests are those that:

 

Reduce the chance that someone who screened regularly will die from cancer.

Have more potential benefits than harms. (Possible harms of screening tests include bleeding or other physical damage, inaccurate test results, and over diagnosis—the diagnosis of cancers that would not have caused problems and did not need treatment.)

Diagnosing cancer at its earliest stages often provides the best chance for a cure.

For few cancers, studies show screening tests can save lives by diagnosing cancer early. For other cancers, screening tests are recommended only for people with increased risk of their life.

Track 17: Cancer Vaccines

 

Cancer vaccines generally either treat existing cancer or prevent development of cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells and pure antigens. Sometimes a patient’s own immune cells are removed and naked to these substances in the lab to create the vaccines.

 

Tracks 18: Clinical Trials in Cancer Treatment

 

Before any advance treatment is used with people in clinical trials, researchers work for many years to understand its effects on cancer cells in the lab and in animals. They also try to figure out the side effects it may cause.

 

Track 19: Innovations in Cancer Research and Oncology

 

Continuous Anticancer drug discovery and development is difficult to find a complete cure for cancer. Due to the drug resistance developed by tumour cells for existing treatments, this is becoming a mandatory approach to fight the disease.

 

Scientific investigations on inhibitors of checkpoint CHK1 can be another milestone for anticancer drug discovery approach.

Cancer cells are specifically dependent on molecular chaperones and related proteins that regulate homeostasis. These are promising targets for new anticancer therapies.

Deregulated apoptosis is hallmark of cancer and Bcl-2 family of proteins are pivotal to mediating the pathway of this process. Inhibiting their process can be a significant way for developing new anticancer drugs. Many plant sources are known to be important sources of novel anti-cancer properties.

 

Market Analysis

The term ‘Cancer’ can be defined as the uncontrolled growth of cells in the body. It is an outcome of cascading events involving abnormal cell divisions. These cell divisions occur due to various biotic and abiotic factors. These factors may include physical exposure to certain substances or chemicals which are also termed as carcinogens; exposure to radiations that involve both ionizing and non-ionizing. Cancer is also known to be linked with some autoimmune diseases such as celiac disease, crohn’s disease. There are more than 200 types of cancer. Some diagnostic techniques are used to diagnose the cancer, cancer growth, affected area and severity of the disease such as MRI, CT Scan, PET scan, Ultrasound, some laboratory biochemical analysis tests, to detect the presence of excess levels of certain substances that may also be the cause of cancer.

 

Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place. When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumours.

 

Importance and Scope

 

Cancer Summit 2022 will be the best platform for all the scientist, radiologists, oncologists, research scholars, students who are working in this field to exchange their knowledge related to Cancer and oncology. This international event is an effort to find an alternative for invasive imaging technique against cancer like Liver Cancer, Brain Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Cancer in adults & cancer in children.

 

North America is the leading regional marketplace for cancer diagnostics with a part of approximately 40.7% of the general cancer diagnostics market in terms of income in 2020, shadowed by Europe which accounted for around 29.1% share in the market.

 

Cancer Research Centres:

 

A. K. Khan Healthcare Trust

Aalborg Hospital - Department of Oncology

Aarhus University Hospital - Department of Oncology

Abbotsford Cancer Centre

bramson Cancer Centre

ddenbrookes Oncology Centre

Aichi Cancer Centre

Albert Einstein Cancer Centre

Allan Blair Cancer Centre

Alvin J. Siteman Cancer Centre

Arizona Cancer Centre

Atlantic Cancer Research Institute

Azienda Ospedaliera Arcispedale S. Maria Nuova

Comprehensive Cancer Centre Ulm

Comprehensive Cancer Centre Vienna

Comprehensive Cancer Centre - Vratsa

Comprehensive Cancer Centre the Netherlands

Cork University Hospital: Cancer Centre

Country Dispensary for Oncological Diseases, Shumen

Cross Cancer Institute

Dan L. Duncan Cancer Centre

Dana-Farber/Harvard Cancer Centre

David H. Koch Institute for Integrative Cancer Research at MIT

Delhi State Cancer Institute

Department of Paediatric Haematology and Oncology

Dharmais Hospital - National Cancer Canter

District Dispensary for Oncological Diseases, Plovdiv

Dokuz Eylül University, Institute of Oncology

Duke Cancer Institute

Dundee Cancer Centre

Erasmus MC Daniel den Hoed Cancer Centre

European Institute of Oncology

Fakkous Centre for Cancer and Allied Diseases

Feist-Weiller Cancer Centre

Finsen Centre, Rigshospitalet - Department of Oncology

FN Brno - Department of Paediatric Oncology

Fondazione IRCCS Istituto Nazionale dei Tumori

Fox Chase Cancer Centre

Fraser Valley Cancer Centre

Fred and Pamela Buffett Cancer Centre

Fred Hutchinson Cancer Research Centre

Fudan University Shanghai Cancer Centre

Fundacion Instituto Valenciano de Oncologia (IVO)

Galway University Hospital: Cancer Services

General University Hospital in Prague

Georgetown Lombardi Comprehensive Cancer Centre

Georgia Regents University - Cancer Centre

Grand River Regional Cancer Centre

Gujarat Cancer & Research Institute / Gujarat Cancer Society

Harold C. Simmons Cancer Centre

Helsinki University Central Hospital

Henry Moore Institute of Oncology

Herbert Irving Comprehensive Cancer Centre

Herlev Hospital - Department of Oncology

Higashi Sapporo Hospital

Holden Comprehensive Cancer Centre

Hollings Cancer Centre

Hospital Ceske Budejovice - Comprehensive Cancer Centre

Hospital de Clínicas "Dr. Manuel Quintela"

Huntsman Cancer Institute

 

Major Cancer Associations Worldwide:

 

American Association for Cancer Research

Virginia Cancer Institute

American Brain Tumour Association

American Society of Paediatric Haematology/Oncology

Association of Cancer Physicians

American Childhood Cancer Organization

American Society of Clinical Oncology

Australasian Lung Cancer Trials Group

International Cancer Research Partnership (ICRP)

American Association for Cancer Research (AACR)

American Society of Clinical Oncology (ASCO)

International Agency for Research on Cancer (IARC)

Cancer Society of New Zealand

Irish Cancer Society

Australian Cervical Cancer Foundation

Medical Centre Cologne

Cancer Research UK

Australian Prostate Cancer Research

Peter McCollum Cancer Centre

The European Cancer Organization (ECCO)

German Cancer Research Centre

In Asia Pacific

 

Medical Excellence JAPAN

Japan Community Health care Organization Chukyo Hospital

Aichi Cancer Centre Hospital

Japanese Red Cross Nagoya Daiichi Hospital

Kyoto University Hospital

Dokkyo Medical University Hospital

Japan Hospital Association

Aizawa Hospital

Medical Excellence JAPAN

Japan Community Health care Organization Chukyo Hospital

Aichi Cancer Centre Hospital

Japanese Red Cross Nagoya Daiichi Hospital

Kyoto University Hospital

Dokkyo Medical University Hospital

Japan Hospital Association

Aizawa Hospital

University Hospital Kumamoto University

International Medical Centre of Japan

The Asia-Pacific Urogynecology Association

The Asia-Pacific Cancer Society Training

Asian Cancer Foundation India

The Max Foundation

Childhood Cancer International Netherlands

The Asia Pacific Prostate Society

Market Analysis Report

 

The cancer diagnostics market is expected to grow at a CAGR of 11.8% during the forecast period 2017-2023. There are several methods of diagnosing cancer today such as biopsy based, endoscopy based, imaging procedure, tumour cancer diagnostics and many more. Population affected with cancer is showing a tremendous growth during last few years, which create the requirement of advanced technology for diagnosis cancer on early stage. According to the American Cancer Society, in 2017, it is estimate that around 161,360 new cases of prostate cancer will be diagnosed and around 26,730 deaths occur owing to prostate cancer in the United States. Thus, many companies are involved in collaboration in order to provide better technology for diagnosis the cancer. In this regards, in January, 2015, Roche and Qualcomm Incorporated entered into a strategic collaboration to improve remote monitoring and management of patients with chronic disease.

The total cost of cancer therapeutics and medicines used in supportive care– measured at the ex-manufacturer price level before the application of rebates or other price concessions – reached $107 billion in 2015, representing an increase in constant dollars of 11.5% over the prior year.

 

Annual growth in the oncology drug market is expected to be 7.5 – 10.5 % through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes.

 

about $51.2 billion in 2017 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. It includes current issues and trends affecting the industry, costs and factors influencing demand. The report covers biological products in development, biological products in clinical trials, and currently marketed and late-stage development biologic cancer products.

 

 

To Collaborate Scientific Professionals around the World

Conference Date February 10-11, 2022

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


The Piaget Limelight Stella aims to evoke feelings of freedom, power, and independence through its heavy use of the moon as an iconographic symbol. Not only does the moon take centre stage in the watch s only serious complication, it also supposedly acts as a totem of femininity, silent strength, and balance. Luxury fake Piaget watches asserts that the characteristics of the moon are often those associated with femininity. watches replica replica watches In some places, this designedly empowering rhetoric sounds a little generalizing to me, but I believe the comparisons are made in a complimentary, rather than patronizing, manner.